Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SGPP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
METTL25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR1908 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC11A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TIAM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARRB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CARD10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SNRK-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
FBRSL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP6V0E2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929584 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MARCH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HTRA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLIRP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOCAD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CERK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF4ENIF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on